Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2018: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
We analyzed the effects of Toll-like receptor (TLR) 2 or TLR3 signals on myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) in tumor-bearing mice. TLR3 activation induced cytotoxic activity of MDSCs against cancer cells, leading to tumor growth inhibition. In combination with radiation treatment, TLR3 ligand-stimulated TAMs enhanced the radiosensitivity of cancer cells to potentiate therapeutic effect. In contrast, TLR2 stimulation enhanced the immunosuppressive activity of MDSCs and TAMs, resulted in decreasing therapeutic efficacy. These results suggest that activation of TLR signaling in MDSCs and TAMs has a significant impact on cancer progression.
|